Arden Trust CO Immuno Gen, Inc. Transaction History

Arden Trust CO

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 20, 2022	SELL	$4.48 - $6.47 $1,742 - $2,516	-389 Reduced 2.59%	14,657 $70,000
Q2 2022 Jul 12, 2022	SELL	$3.15 - $5.76 $189 - $345	-60 Reduced 0.4%	15,046 $68,000
Q1 2022 Apr 11, 2022	SELL	$4.26 - $7.48 $11,847 - $20,801	-2,781 Reduced 15.55%	15,106 $72,000
Q4 2021 Jan 24, 2022	SELL	$4.75 - $7.5 $665 - $1,050	-140 Reduced 0.78%	17,887 $133,000
Q3 2021 Oct 12, 2021	SELL	$5.02 - $6.59 $662 - $869	-132 Reduced 0.73%	18,027 $102,000
Q2 2021 Jul 19, 2021	SELL	$5.79 - $8.6 $4,093 - $6,080	-707 Reduced 3.75%	18,159 $119,000
Q1 2021 Apr 23, 2021	SELL	$6.5 - $10.53 $3,451 - $5,591	-531 Reduced 2.74%	18,866 $153,000
Q4 2020 Jan 15, 2021	SELL	$3.7 - $7.66 $710 - $1,470	-192 Reduced 0.98%	19,397 $125,000
Q3 2020 Oct 15, 2020	SELL	$3.45 - $4.89 $9,439 - $13,379	-2,736 Reduced 12.26%	19,589 $71,000
Q2 2020 Jul 09, 2020	BUY	$3.32 - $5.34 $7,682 - $12,356	2,314 Added 11.56%	22,325 $102,000
Q1 2020 Apr 16, 2020	BUY	$2.12 - $6.8 $6,790 - $21,780	3,203 Added 19.06%	20,011 $68,000
Q4 2019 Jan 17, 2020	SELL	$2.25 - $5.8 $8,480 - $21,860	-3,769 Reduced 18.32%	16,808 $86,000
Q3 2019 Oct 09, 2019	SELL	$2.22 - $3.39 $410 - $627	-185 Reduced 0.89%	20,577 $49,000
Q2 2019 Jul 23, 2019	BUY	$1.8 - $3.3 $37,371 - $68,514	20,762 New	20,762 $45,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Arden Trust CO, based on Form 13F filings with the SEC.

Stay updated on Arden Trust CO with notifications on news.